These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7215973)

  • 1. [Determination of optimal diphenylhydantoin dosage by monitoring serum concentrations].
    Weintraub M; Halkin H; Shaked Y; Almog S
    Harefuah; 1980 Oct; 99(8):213-5. PubMed ID: 7215973
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determination of diphenylhydantoin (DFH) in plasma in patients with epilepsy].
    Borgå O; Lund L; Sjöqvist F
    Lakartidningen; 1969 Oct; 66():Suppl 3:89-98. PubMed ID: 5383812
    [No Abstract]   [Full Text] [Related]  

  • 3. [Control of diphenylhydantoin dosage in epileptic seizures by determination of the serum levels].
    Hirschmann J
    Med Welt; 1969 Mar; 13():705-10. PubMed ID: 5784349
    [No Abstract]   [Full Text] [Related]  

  • 4. [Determination of serum diphenylhydantoin during antiepileptic therapy].
    Müller-Stüler M
    Nervenarzt; 1976 Apr; 47(4):244-7. PubMed ID: 1272481
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies of anticonvulsant levels in epileptics. I. Serum diphenylhydantoin concentrations in a group of medically indigent outpatients.
    Haerer AF; Grace JB
    Acta Neurol Scand; 1969; 45(1):18-31. PubMed ID: 4979531
    [No Abstract]   [Full Text] [Related]  

  • 6. Diphenylhydantoin dosage.
    Eadie MJ; Tyrer JH; Hooper WD
    Proc Aust Assoc Neurol; 1973; 10(0):53-9. PubMed ID: 4792162
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anti epileptic therapy with diphenylhydantoin with serum controls in childhood. Clinical experiences].
    Nolte R; Brügmann G; Besch W
    Bibl Psychiatr; 1975; (151):43-8. PubMed ID: 1156347
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum level of phenobarbital or/and diphenylhydantoin in epileptics with some preexisting serum lipid alterations. Correlations with the treatment efficiency in epilepsy.
    Rogozea R; Florea-Ciocoiu V; Balaita C; Luca N
    Acta Neurol Belg; 1981; 81(1):24-32. PubMed ID: 7223355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Some experience in antiepileptic treatment drugs monitoring in clinic].
    Li J
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Jun; 21(3):145-8, 188-9. PubMed ID: 2906582
    [No Abstract]   [Full Text] [Related]  

  • 10. [Results of phenytoin monitoring in patients with epilepsy].
    Wichliński LM; Sieradzki E; Mazur R; Gosk-Kowalska T; Gruchała M
    Pol Tyg Lek; 1982 Nov; 37(45):1345-8. PubMed ID: 7163089
    [No Abstract]   [Full Text] [Related]  

  • 11. The value of serum diphenylhydantoin (phenytoin) levels in the management of epilepsy.
    Reynolds EH
    Proc R Soc Med; 1975 Feb; 68(2):102-4. PubMed ID: 1166035
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum diphenylhydantoin, triglyceride and cholesterol concentration.
    Reimer DR; Nagaswami S
    N Engl J Med; 1973 Oct; 289(15):808-9. PubMed ID: 4728765
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of spectrophotometric and gas-liquid chromatographic measurements of serum diphenylhydantoin concentrations in epileptic out-patients.
    Janz D; Schmidt D
    J Neurol; 1974 Jun; 207(2):109-16. PubMed ID: 4135844
    [No Abstract]   [Full Text] [Related]  

  • 14. [Rational phenytoin therapy: a method for individualizing dosage].
    Wu JZ
    Zhonghua Yi Xue Za Zhi; 1986 Mar; 66(3):134-6, 188. PubMed ID: 3094864
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diphenylhydantoin in the comprehensive treatment of epileptic attacks].
    Kolínová M; Kristof M; Maresová S
    Cesk Neurol Neurochir; 1982 Nov; 45(6):410-7. PubMed ID: 7151206
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical value of determination of serum concentration of antiepileptics.
    Wang L; Zuo QH; Liu SR; Wang SH
    Chin Med J (Engl); 1984 Mar; 97(3):165-70. PubMed ID: 6432478
    [No Abstract]   [Full Text] [Related]  

  • 17. [The diffusion of diphenylhydantoin across the cellophane membrane of the artificial kidney in a patient with uremia and epilepsy].
    Desjacques P
    Schweiz Rundsch Med Prax; 1972 Mar; 61(13):418-23. PubMed ID: 5020101
    [No Abstract]   [Full Text] [Related]  

  • 18. [Daily fluctuations of plasma diphenylhydantoin in patients treated with diphenylhydantoin and sodium valproate].
    Pisani F; Di Perri R
    Acta Neurol (Napoli); 1981 Feb; 3(1):61-3. PubMed ID: 6787844
    [No Abstract]   [Full Text] [Related]  

  • 19. [Determination of blood level of diphenylhydantoin in the treatment of epilepsy. The need for monitoring].
    Lazowski J; Radzikowska B; Zadrozyńska E
    Wiad Lek; 1977 Oct; 30(20):1613-6. PubMed ID: 930076
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical utility of six methods of predicting phenytoin doses and plasma concentrations.
    Murphy JE; Bruni J; Stewart RB
    Am J Hosp Pharm; 1981 Mar; 38(3):348-54. PubMed ID: 7223747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.